Gastric cancer care: From evidence to practice
ESMO Asia 2017 - Industry satellite symposium
Chaired by Ian Chau with Jae-Ho Cheong, Eva Segelov, and Kohei Shitara
Held on Friday 17th November at the Suntec Singapore Convention and Exhibition Centre
This industry satellite symposium discussed the latest in gastric cancer treatment and molecular analysis, and provided advice on how to incorporate the ever-changing current optimal therapeutic strategies into everyday clinical practice, using case presentations to stimulate interactive discussion. We hope that by sharing expert experience and perspectives, it can help navigate the complexities of gastric cancer care and provide you with knowledge that you will be able to seamlessly apply to your own clinical practice.
15-01-2018 | Video | Gallery
Scroll below to see interviews with Ian Chau, Eva Segelov, Jae-Ho Cheong and Kohei Shitara
Professor Ian Chau, Royal Marsden Hospital, UK (symposium chair)
Professor Jae-Ho Cheong, Yonsei University College of Medicine, Yonsei, Korea
Professor Eva Segelov, Monash University and Monash Health, Melbourne, Australia
Dr Kohei Shitara, National Cancer Center Hospital East, Kashiwa, Japan
- Explain the current guidelines for peri-operative chemotherapy for Stage II/III proximal gastric cancer and how they will change in response to the new standards of care raised by trial data.
- Explain the use of molecular analysis in colorectal cancer, how it compares and contrasts with the current evidence base for gastric cancer, and how we can use developments in colorectal cancer to guide molecular analysis in gastric cancer.
- Discuss the evidence base supporting the current optimal therapeutic strategies for gastric cancer and how to implement these into a treatment plan during their daily practice and within the context of Asian patients.
This program was made possible thanks to independent educational sponsorship from Eli Lilly and Company.
Produced by Springer Healthcare IME.
This activity was planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Imedex and Springer Healthcare IME.
Imedex is accredited by the ACCME to provide continuing medical education for physicians.
This activity was approved for AMA PRA Category 1 Credit™.
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK